Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation Cell Therapy 2014

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

Presenter: Thomas J. Povsic

January 23, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

PERFECT-Phase III Clinical TrialKey Study Elements

Presenter: Gustav Steinhoff

January 22, 2014

Presentation Cell Therapy 2014

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Presenter: Joseph C. Wu

January 22, 2014

Presentation Cell Therapy 2014

12 months CMR and long-term clinical results of the Swiss AMI Study

Presenter: Daniel S?rder

January 22, 2014

Presentation Cell Therapy 2013

NIH Clinical Trial Research Network

Presenter: Timothy D. Henry

January 24, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation Cell Therapy 2012

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Presenter: Stephen G. Ellis

January 26, 2012

Presentation Cell Therapy 2012

NIH Clinical Trial Research Network

Presenter: Jay H. Traverse

January 26, 2012

Presentation Cell Therapy 2012

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Timothy D. Henry

January 25, 2012

Presentation Cell Therapy 2012

Trial 4: BMAC for CLI: A Phase III Trial

Presenter: Thomas F. O'Donnell

January 25, 2012

Presentation Cell Therapy 2012

Placenta-Derived Cells for CLI

Presenter: Christof Stamm

January 25, 2012

Presentation Cell Therapy 2012

Platelet-Cell-therapy Clinical Strategy: BioParadox, Inc.

Presenter: Todd J. Brinton

January 25, 2012

Advertisement

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

Clinical Trials in Peripheral Arterial Disease

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

PERFECT-Phase III Clinical TrialKey Study Elements

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

12 months CMR and long-term clinical results of the Swiss AMI Study

NIH Clinical Trial Research Network

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

BMAC for CLI: Status of a Phase 3 Trial

IMPACT Clinical Trial Program: Findings and Strategic Update

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

NIH Clinical Trial Research Network

IMPACT Clinical Trial Program: Findings and Strategic Update

Trial 4: BMAC for CLI: A Phase III Trial

Placenta-Derived Cells for CLI

Platelet-Cell-therapy Clinical Strategy: BioParadox, Inc.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content